Stratatech receives $247 million contract to develop skin product. Stratatech will use the contract money to fund a final phase clinical trial for its flagship StrataGraft product, which is delivered to users frozen, giving it …
Uncategorized
3D brain-on-a-chip helps predict drug neurotoxicity
NIH-funded engineered brain tissue identifies toxins correctly 9 out of 10 times To help test the toxicity of new drugs, NIBIB researchers have engineered a 3D brain organoid—a miniature organ structure that attempts to mimic the …
U.S. Senator Baldwin Pushes For New Standards In Regenerative Medicine Industry
U.S. Sen. Tammy Baldwin has introduced new legislation to create industry standards for regenerative medicine. The bill would create a public-private board to set guidelines for regenerative medical products, including those developed from stem cells. Dr. …
New way of developing tissue mimics brain function, has potential to eventually replace animal testing
UW scientists develop brain-like structure to improve drug safety testing. University of Wisconsin scientists have created a structure that mimics brain function and may be used to determine the safety of pharmaceutical drugs and industrial …
“Brain in a Dish” could replace toxic animal test
Scientific American and Francis Collins, NIH director, discuss the potential potential impacts of Michael Schwartz’s human brain models on hydrogels. These “Brain in a Dish” models may provide a fast, low cost way to screen …
Stem cell-derived brain mimics predict chemical toxicity
Michael Schwartz tested the toxicity of 60 different chemicals on miniature model brains developed using neural progrenitor cells grown on hydrogels. Read Full Articles Here and Here
Why drug companies need human tissue- especially liver
Bill Murphy talks to the Washington Post about the ethics and importance of human tissue in drug testing and development. Read Full Article
The Canadian military wants to use stem cells to help its soldiers heal
Bill Murphy talks to Vice News about the use of stem cells in regenerative technologies capable of healing battlefield injuries Read Full Article
Johnson & Johnson Innovation Center features collaboration with Tissue Regeneration Systems
Johnson & Johnson Innovation Center features collaboration with Tissue Regeneration Systems to develop bioresorbable, implantatable devices for skeletal reconstruction and bone regeneration Watch Video Here
α/β-Peptides Could Offer Low-Cost Alternative To Antibody Drugs
Samuel H. Gellman, William L. Murphy, Katrina T. Forest, and coworkers have designed a two-helix α/β-peptide with afffinity for VEGF and demonstrated its use by inhibiting the growth of cells lining blood vessels, a process …